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Abstract 
Aims. In this paper, we investigated the interaction between magnetic carbon nanotubes (CNTs) and 
mesenchymal stem cells (MSCs) and their ability to guide these cells injected in vivo by using an 
external magnetic field. This could pay the way for the development of new strategies for 
manipulation/guidance of MSCs in regenerative medicine and cell transplantation. Materials and 
methods. MSCs were cultured in a CNT-containing medium. We investigated if CNTs and 
magnetic field can alter cell viability, proliferation rate and the ability of cells to differentiate in 
osteocytes and adipocytes. We also studied the effect of interaction with CNTs in terms of cell 
phenotype and cytoskeletal conformation. Finally we investigated the ability of MSCs labelled with 
CNTs to move towards the magnetic source in vitro and the possibility to be guided into target 
organ in vivo. Conclusion: We have demonstrated that CNTs interact with the MSCs without 
compromising their viability, proliferation rate and their ability to differentiate. We showed that 
CNTs, when exposed to magnetic fields, are able to shepherd MSCs towards the magnetic source 
both in vitro and in vivo. 
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Introduction 
Carbon nanotubes (CNTs) [1] are molecular-scale tubes of graphite carbon with a high aspect ratio: 
lengths varying from several hundred nanometres to several micrometers with diameters of 0.4–2 
nm for single-walled carbon nanotubes (SWCNTs) and 2–100 nm for coaxial multi-wall 
(MWCNTs) types. CNTs exhibit unique properties [2] which account for their substantial scientific 
and industrial interest with thousands of original publications reported annually. In particular, 
biomedical applications for CNTs are currently under intense investigation because of their 
molecular and unique physicochemical properties [3-4]. However the insolubility of CNTs in 
aqueous media has been a major technical barrier to their biomedical applications. The recent 
progress in chemical modification and functionalization of nanotubes has largely overcome this 
problem such that it is now possible to solubilize and disperse CNTs in water, thus enabling their 
use and application in biophysiological environments [5]. Equally important is the recent 
demonstration that bioactive species, e.g., proteins, carbohydrates, and nucleic acids can be 
conjugated with CNTs [6]. Material therapeutic advances are likely to be realized by the 
exploitation of the unique physical properties of CNTs, e.g., hyperthermic cell ablation based on the 
strong near- infrared light absorbance by SWCNTs [7], bacterial electroporation by the field 
emission properties of MWCNTs [8], cell permeabilisation by application of static electric field [9] 
and thermal release from SWCNTs following application of a radiofrequency current for tumour 
ablation [10]. CNTs also possess intriguing magnetic properties which derive from the metal 
catalyst impurities entrapped at CNT extremities during their manufacture, enabling them to react to 
external magnetic fields. This property has been utilised by Cai et al. to develop a physical 
technique for in vitro and ex vivo gene transfer known as ‘nanotube spearing’, capable of effective 
cell transfection with plasmid DNA [11]. Similarly, we have recently demonstrated that MWCNTs 
are able to interact with cells and, when exposed to a magnetic field, induce their migration towards 
the magnetic source [12-13]. 
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The aim of the present paper was to investigate the use of this magnetic force exerted by CNTs in 
the manipulation and homing of mesenchymal stem cells (MSCs). They are bone marrow-derived 
cells with the capacity of replication and differentiation in vitro into several tissues including bone, 
cartilage, stroma, fat, muscle and tendon [14]. MSCs can be isolated by relatively simple procedures 
and then expanded without loss of their ability to differentiate into multiple lineages. As such, these 
cells have several clinical potential in regenerative medicine for repair or replacement of damaged 
tissues. MSCs do not express the haematopoietic markers CD34, CD45 or CD14 and can be 
identified by positive staining for a number of non-specific surface adhesion molecules such as 
CD29, CD44, CD73, CD105, CD 90 [14]. Additionally, MSCs do not express co-stimulatory and 
MHC class II molecules; therefore they escape the immune detection in vivo and for this reason, are 
considered good candidates for cellular therapy in an allogeneic setting [15]. Numerous in-vitro 
studies have demonstrated that MSCs from various species can suppress T-cell proliferation in both 
autologous and alloreactive states. MSCs interact and suppress cell-mediated immune responses 
(dendritic cells, CD4+, CD8+ T cells, NK cells) directly and through soluble factors, evading each 
aspect of the cellular rejection process and acting as universal suppressors of immune reactivity 
[16]. The interactions between allogeneic MSCs and immune cells may play a role in the induction 
of tolerance and offers a new perspective for the reduction of acute rejection of transplants and 
modulation of inflammation. [17-18].  
One of the unresolved problems  in the use of MSCs therapy relates to site specific homing of MSC 
homing to the organ of interest as several studies in animal models have reported that both 
allogeneic or autologous MSCs [19-20-21]  migrate and settle in  many tissue and organs, e.g., 
kidney, skin, thymus, liver, spleen and bone marrow, especially after injury. These findings suggest 
that MSCs may participate in ongoing cellular turnover and replacement in a wide variety of tissues, 
especially following injury. In a seminal study, Francois et al reported the fate and potential 
therapeutic effect of the re-infusion of hMSCs after total body irradiation in the mouse model. 
Whereas in non-irradiated animals, hMSCs homed in low levels in various tissues (lung, bone 
 5 
marrow and muscles) and no significant colonisation was found in other organs. In contrast, total 
body irradiation induced an increase in hMSCs colonization levels in the brain, heart, bone marrow 
and muscles [22]. This observation suggests the potential use of MSCs to repair damaged normal 
tissues after accidental irradiation or in patients submitted to chemo-radiotherapy. Others 
researchers have demonstrated that MSCs are preferentially attracted by injured tissues because 
these express specific receptors or ligands to facilitate trafficking, adhesion, and infiltration of 
MSCs to the injury site [22-23]. Moreover other reports have shown preferential migration of MSCs 
to the lungs following their injection in healthy animals [20-21]. These cells become entrapped in 
lungs presumably as a consequence of significant differences in the diameter of MSC and lumen of 
the pulmonary capillary bed (>15µm vs. 10 µm, respectively). Allers et al reported that lungs are the 
long-term destination site for human MSC in recipient mice [20]. The bio-distribution in the body 
of MSCs is the same irrespective of administration (intravenous or intra-arterial injection).  
Moreover, is time dependent and the level of cell colonization is relatively low in unconditioned 
recipient [20-21]. Thus on the available evidence, MSCs distribute to a wide variety of organs and 
tissues following systemic administration.  This dispersion of the injected cells reduces the intended 
local effect on the target organ. As several clinical applications of MSCs require the administration 
of cells by the intravenous route [24-25-26-27], many researchers are exploring novel technologies 
for stem cell guidance. Recently Kobayashi et al used magnetically labelled mesenchymal stem 
cells with superparamagnetic iron oxide nanoparticles (SPIONs) to guide them to the desired 
osteochondral defects of the patellae after intra-articular injection [28]. The aim of this work is to 
provide a new method for in-vivo stem cell guidance which assures 1) minimal manipulation of 
MSCs, 2) long magnetization 3) negligible citotossicity, and 4) enhanced engraftment of MSCs 
without compromise their therapeutic potency. We demonstrate that MSCs cultured with magnetic 
carbon nanotubes maintain their biological activity in terms of viability and differentiation. 
Moreover they can be shepherded in vitro and guided towards the target organ  in vivo by using an 
external magnetic field.  
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Materials and methods  
MWCNT samples 
MWCNTs (provided by Nanothinx S.A., Greece) were produced by catalytic chemical vapour 
deposition (CCVD or CVD) of hydrocarbon sources on substrates of metal oxides (Al2O3) 
impregnated with metal catalysts (Fe). The MWCNTs produced in this way have been characterised 
previously [29]. Briefly, the carbon content of the sample is 97.06% (i.e., metal particle content 
2.94%), the metal particles being Al and Fe in a ratio Fe/Al of 7±1 (w/w); the amount of amorphous 
carbon in the carbon content is <1% and the nanotube diameter range from 20 to 40 nm. 
Pluronic F127 (PF127, polyoxyethylene-polyoxypropylene block copolymer (Sigma, St. Louis, 
MO) surfactant was dispersed in Dulbecco modified culture medium at a concentration of 0.1%. 
MWCNTs were added to this solution (0.4 mg/ml) which was heated over a hot plate (70°C) with 
magnetic stirring for two hours; the resulting mixture was sonicated with a Branson sonicator 2510 
(Bransonic, CT, USA) at 20 W. The mixture was then centrifuged at 900g for 10 minutes to remove 
residual non-suspended nanotubes and impurities. The concentration of the PF127-CNT solution, 
measured by spectrophotometric analysis [30] was 100 µg/ml. After preparation, a small drop (10 
µl) of dispersion was placed onto a plasma-cleaned silicon wafer and allowed to dry under flux. 
Samples were imaged by Focused Ion Beam (FIB) microscopy which revealed an average length of 
the nanotubes after dispersion of 1 µm. The FIB system used in the present work was FEI 200 
(Focused Ion Beam localized milling and deposition) delivering a 30 keV beam of gallium ions 
(Ga+). 
 
Animals 
Inbred male Wistar-Furth (WF) and Lewis rats, weighing 275-300g, were purchased from Charles 
River Laboratories (Italy). The animals were fed on standard rodent chow (Rieper, Italy) and water 
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ad lib, and were kept under a 12 h light/dark cycle. All the experimental procedures were carried 
out with the approval of the Ethical Committee for Animal Experimentation of the University of 
Pisa. 
 
MSC isolation and culture 
Rat bone marrow cells were collected from tibia and femur of Wistar Furth animals following the 
Dobson procedure [31]. Total nucleated cells were cultured in Dulbecco modified culture medium 
(Sigma-Aldrich, Italy) supplemented with 10% fetal bovine serum (Eurobio, Italy), 1% L-glutamine 
(Sigma-Aldrich, Italy), penicillin (Eurobio, 50U/mL), streptomycin (Eurobio, 50µg/mL), 
amphoterycin B (Sigma-Aldrich 0,2µg/mL) and incubated at 37°C in fully humidified atmosphere 
containing 95% air and 5% carbon dioxide. After 7 days half of the culture medium was changed. 
On reaching confluence, the adherent cells were detached by 0.05% trypsin and 0.02% EDTA for 
5–10 min at 37°C, harvested and washed with HBSS and 10% FBS and finally re-suspended in 
complete medium (primary culture, P0). Cells were re-seeded at 104 cells/cm2 in 100-mm dishes 
(P1) for both in vitro differentiation assessment and further cellular expansion which was achieved 
by successive cycles of trypsinization and re-seeding. The frequency of Colony Forming Units-
Fibroblasts (CFU-F) was measured using the method of Castro-Malaspina. Visible colonies with 50 
or more cells (the conventional value for defining a colony) were counted and referred to 106 plated 
cells (no. of CFU-F/106 TNC). 
 
MSC-CNT samples preparation 
MSC cells were seeded in a T 25 flask at concentration of 2*105 with DMEM culture medium after 
six hours of incubation the medium was changed with modified medium added with PF127-CNTs. 
After three days the modified medium was changed again and at the 5th day the cells were ready to 
be used for the in vitro and in vivo assays. 
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Immunophenotyping and differentiation of MSC and MSC-CNT sample 
The morphologically homogeneous population of untreated MSC and of MSC cultured respectively 
with PF127-CNTs and PF127 alone for 5 days, were analysed for the expression of cell surface 
molecules using flow cytometry procedures: MSC were recovered from flasks by trypsin–EDTA 
treatment and washed in HBSS and 10% FBS. Aliquots (1.5×105 cells/100µl) were incubated with 
the following conjugated monoclonal antibodies: CD34, CD45, CD11b (in order to quantify 
hemopoietic–monocytic contamination), CD90, CD106, CD73. Non-specific fluorescence and 
morphologic parameters of the cells were determined by incubation of the same cell aliquot with 
isotype-matched mouse monoclonal antibodies. Incubations were performed for 20 min, and 
thereafter the cells were washed and 7-AAD was added in order to exclude dead cells from the 
analysis. Flow cytometric acquisition was performed by collecting 104 events on a FACScan (argon 
laser equipped; Becton Dickinson) instrument, and data were analysed on DOT-PLOT bi-
parametric diagrams using CELL QUEST software (Becton Dickinson, Franklin Lakes, NJ, USA).  
The ability of untreated MSC and of MSC cultured for 5 days respectively with PF127-CNTs and 
PF127 alone, to differentiate along osteogenic and adipogenic lineages was assayed, as described 
previously by Pittenger et al [14]. Osteogenic and adipogenic differentiation were evaluated by 
cytochemical analysis. Petri dishes were stained to assess extracellular matrix mineral bound by 
Alizarin Red-S. Adipogenic differentiation was evaluated by Oil Red O stain for lipid-rich 
vescicles. 
 
Cell migration assay 
MSCs were seeded in two 30 mm Petri dish at concentration of 20000 cells/ well with DMEM 
culture medium and incubated for six hours to allow cell attachment, subsequently the medium was 
changed and the two samples were cultured for 5 days in media added with PF127-CNTs and 
PF127 respectively (test and control cultures). 3 hours after the treatment a magnet was then placed 
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close to the wells. The magnet used was a Neodymium cubic magnet (N48, Residual Induction 1.41 
T, cube late 12 mm). Cell migration dynamics were followed for 72 h after magnet placement. Test 
and control were cultured in PF127-CNT and PF127-modified media respectively for the duration 
of the assay. 
In order to obtain instantaneous cell pictures and to enumerate the cell concentration close and far 
from the magnet, cells were treated with SYTO 82 orange fluorescent nucleic acid stain (Invitrogen, 
Milan, Italy): cells were washed twice in 2 ml phosphate buffered solution (PBS), incubated for 30 
min with Syto 82 (5 µM in PBS) and then fixed in paraformaldeide 4 %. Static image acquisition 
was carried out with a Nikon TE2000U fluorescent microscope equipped with NIKON DS-5MC 
USB2 cooled CCD camera. Image analysis was performed with NIS Elements imaging software. 
Moreover real-time image acquisition was performed with a Zeiss Axiovert 200 microscope 
equipped with an Axiocam MRm. Cell culture dish was placed in a temperature-controlled CO2 
incubator camera (Okulab). Cell migration dynamics was monitored for 72 hours and digital images 
acquired by microscopy using a 20 x Ph2 objective and stored for subsequently analysis. Images 
were acquired at intervals of 30 minutes in a fixed position. 
 
Cell viability assay 
WST-1 (tetrazolium salt 2-(4-iodophenyl)-3-(4-nitophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazoilium) 
cell proliferation assay was performed on MSC cultured with CNTs for 5 days. 25x10³ cells were 
seeded into a 96-well plate and then incubated with the culture media. After cell adhesion (six 
hours), 10µl of WST-1 solution (as described in quick cell proliferation assay kit, BioVision, USA) 
were added to the culture media and the plate was incubated for 1 h in standard conditions. The 
absorbance was measured on a Versamax microplate reader (Molecular Devices, Sunnyvale, CA, 
USA) at a wavelength of 450 nm with background subtracted at 650 nm. The results are given 
relative to the untreated control. 
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Cell staining and evaluation of apoptotic cell death 
MSC cell death was evaluated by Hoechest 33258 on samples exposed for 5 days to MWCNT-
modified culture media and compared with control and cells incubated in PF-127 0.01% modified 
culture medium without MWCNTs respectively. 25x103 MSCs were cultured in a 24 well plate, 
equipped with cover slips. Hoechst 33258 (Invitrogen, Milan, Italy) 0.5ug/ml staining of cell nuclei 
(excitation 346 nm; emission 460 nm) enables determination of the presence of DNA condensates 
indicative of apoptosis [32]. After washing with PBS, cells were fixed with 40 g/l para-
formaldehyde in PBS, incubated for 30 min at 4°C and then washed three times with PBS before 
further incubation for 20 minutes at 37°C with 0.5 µg/ml Hoechst 33258 in PBS. The cells were 
washed again with PBS and dried, subsequently each cover slip was inverted onto a slide containing 
10 µl of mounting media (VECTASHIELD mounting media, Vector Laboratories, Burlingame, CA, 
U.S.A.); the excess mounting medium was removed with fiber-free paper and each cover slip was 
sealed with regular transparent nail polish and allowed to dry for 3 min. 
The pyknotic cells were examined with a Zeiss epifluorescence microscope (Carl Zeiss, 
Oberkochen, Germany). The number of apoptotic nuclei was counted on five randomly selected 
areas from three cover slips from each experimental group. Results are expressed as number of 
apoptotic cells as a percentage of the total number of cells and compared to the control sample. 
 
Monitoring cell growth rate 
To evaluate the effects of the CNTs and/or the magnetic field on the MSCs growth rate, we 
performed four experimental groups in which MSCs were cultured in different conditions:  
1. MSC: cells cultured in cell culture medium;  
2. MSC-B: cells cultured in cell culture medium placed under the effect of the magnetic field; 
3. MSC-CNT: cells cultured in PF127-CNT modified medium;  
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4. MSC-CNT-B: cells cultured in PF127-CNT modified medium under the effect of the 
magnetic field. 
1,5*105 MSCs were seeded in a 6 well-plate and 2,5 ml of medium were added in each well; cells 
were removed by trypsinization at 24, 48, 72 and 96 hours and counted in a Thoma’s camera. We 
calculated the doubling time (Td), assuming a constant growth rate, by using the following formula: 
Td = (t2-t0)*ln (2)/ ln (q2/q0), where q0 represent the cell number at time t0 and q2 the cell number at 
time t2. 
 
Staining of cell cytoskeletal actin  
The cytoskeletal rearrangement of MSC-CNT cells in the presence of a magnetic source was 
studied by means of actin staining. MSCs were seeded in a 12 well plate, equipped with cover slips, 
at concentration of 5*104 cells/ well and incubated for 6 h in DMEM culture medium to allow cell 
attachment. Thus the medium was changed and the samples were cultured for 5 days in media 
added with PF127-CNTs. We used as comparison cells in complete DMEM  and cells incubated in 
PF-127 0.01% modified culture medium. 6 hours after the addition of CNTs to the cells a magnet 
was placed close to the wells. The actin staining was performed 5 days after incubation of cells with 
the MWCNT and exposed to the magnetic field. The culture medium was removed and the cells 
were washed with PBS 1x at 4C° and then fixed/permeabilized with methanol at -20° C for 30 min. 
At the end of incubation cells were washed 4 times with PBS 1x at 4°C and incubated overnight at 
4°C with the primary Actin antibody (mouse monoclonal, C-2:sc-8432 Santa Cruz Biotechnologies, 
Germany) .Subsequently the sample was washed again 4 times with PBS at 4°C and incubated 1 h 
at room temperature with the secondary antibody (goat anti-mouse IgG-TR, sc-2781 Santa Cruz 
Biotechnologies, Germany). After incubation the cells were washed with PBS (4 times) and dried; 
each cover slip was removed from each well and was inverted onto a slide containing 10 µl of 
mounting media (VECTASHIELD mounting media, Vector Laboratories, Burlingame, CA, 
U.S.A.); the excess mounting medium was removed with fiber-free paper and each cover slip was 
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sealed with regular transparent nail polish and allowed to dry for 3 min. The images were analyzed 
by confocal microscopy. 
 
MSC-CNT cells transplantation 
Inbred male Lewis (230-250 g) rats were used as recipient of MSC-CNT cells. Briefly rats were 
anaesthetized by intra-peritoneal injection of Zoletil 100 (tiletamin 90 mg/Kg and zolazepam 10 
mg/Kg, Virbac s.r.l., i.p.) and the portal vein was exposed through a midline incision under the 
spine. 106 cells suspended in 0.5 mL of PBS solution were injected and re-flushed 2-3 times, into 
the portal vein. 
The following groups of transplant were performed: animals receiving untreated MSCs (control 
group); a); animals receiving MSC-CNT cells (group b) and animals receiving MSC-CNT cells in 
presence of a magnetic source (group c). 
In group c after the MSC-CNTs injection into the portal vein a Neodymium cubic magnet (N48, 
Residual Induction 1.41 T, cube late 12 mm) was placed for ten minutes on rat liver to control the 
homing of the cells. After suture closure of the laparotomy, a belt equipped with a bigger magnet 
was placed on the rat’s abdomen for 24 hours. 
 
Histological procedure 
A total of 5 animals were used for this part of the study. The liver, both lungs and both kidneys 
were harvested from all animals. The organs were fixed in buffered 10% formalin, immediately 
after their removal, for 24 hours. A total of 248 blocks in paraffin-embedded tissues were obtained 
after standard procedure for histological preparation. We prepared 2 slides (thickness 2µm) for each 
block to prepare Hematoxylin/Eosin and Perls staining. The Perls staining was performed using a 
kit following the manufacture’s instructions (Perls Microstain, DiaPath, Martinengo, Italy). The 
valuation of positive cells for Perls staining was done by software for morphological analysis 
(AnalySIS b, Olympus). The pathologist selected the positive cells using different magnification 
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(10X, 20X and 40X). The total output data were obtained automatically at the end of each 
observation in electronic sheet format. All data were uploaded in statistical analysis program 
(GraphPad Prism5.0, GraphPad software). 
 
Statistics 
Values are reported as mean ± standard error of the mean (S.E.M.). Statistical significance was 
assessed by one way analysis of variance (ANOVA) followed by post-hoc comparison test (Tukey) 
at P<0, 05.  
 
Results 
In-vitro studies 
Aqueous solutions of CNTs were made with PF127, a surfactant with MW 12,600 soluble in water 
[33]. PF127 surfactant wraps the surface of the nanotubes (PF127-CNTs), thus avoiding their 
aggregation by a steric mechanism. The PF127-CNT solution was analysed after its preparation and 
before use by FIB imaging which confirmed that the nanotubes were dispersed singly and were of 
uniform length (about 2±0.5 µm). PF127-CNT modified medium, prepared by mixing PF127-CNT 
solution and cell culture medium at ratio 1:10 (v/v), contained 10 µg/ml of MWCNTs and 0.01% of 
PF127. PF127-CNT-modified medium was stable over a month from preparation with no evidence 
of nanotube bundling or precipitation. PF127 modified medium, prepared by mixing PF127 solution 
and cell culture medium at ratio 1:10 (v/v), contained 0.01% of PF127. 
When MSCs are cultured in a CNT-containing medium, the nanotubes interact with the cells 
resulting in “magnetisation” of the cells as confirmed by atomic force microscopy (AFM) analysis 
(see Fig-1 supplementary materials). To establish the ability of CNTs to induce the migration of 
MSCs in the presence of an external magnetic field, test and control MSC cultures, grown for 5 
days in PF127-CNT medium and PF127 medium respectively, were exposed to the magnetic field 
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generated by a permanent magnet. In a previous publication we showed how the strength of the 
magnetic field generated by the magnet is a function of the distance from the magnetic pole [13]. 
After 72 h of exposure to the magnetic field, MSCs were stained with a fluorescent probe for cell 
imaging and counting. The images captured at different distances from the magnet revealed that the 
magnetic field induced migration of the MSCs cultured in PF127-CNT modified medium towards 
the magnetic source but no such migration was observed with the control culture (Fig. 1A). Data 
analysis (Fig. 1B) provided the cell density for test and control culture MSCs in the Petri dish. 
The migration dynamics of a single cell was followed by placing the test culture in a temperature-
controlled CO2 incubator camera (see Fig-2 supplementary materials). The lens objective was 
focused onto the target cell which was monitored for 72 hours. This figure shows 5 frames acquired 
at interval of 30 minutes in the same position (8 mm from the magnet pole).  
MSCs were grown for 5 days in cell culture medium (K), in PF127-CNT modified medium and 
PF127 modified medium and cell proliferation was measured (Fig. 2). Cytotoxicity was expressed 
as percentage viability normalized to the control. We also performed the Hoechst apoptosis assay to 
exclude nanotubes induced apoptosis after their interaction with MSCs (see the Fig-3 
supplementary materials).   
We used four experimental groups for the evaluation of the effects on MSC growth rate by the 
CNTs and under the influence of the magnetic field (Fig.3): (I) cells cultured in cell culture medium 
(MSC); (II) cells in cell culture medium in presence of the magnetic field (MSC-B); (III) cells 
cultured in PF127-CNT modified medium (MSC-CNT) and (IV) cells cultured in PF127-CNT-
modified medium in the presence of the magnetic field (MSC-CNT-B). These studies confirmed 
that CNTs do not induce cell toxicity or influence normal cell growth rates.  
The phenotype of the cells treated with CNT was analysed by flow cytometry and the expression of 
markers was compared with that of untreated MSCs (table 1). We observed that after the incubation 
with nanotubes the cells maintain the same expression pattern as the control sample. In addition we 
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confirmed the ability of stem cells to differentiate in osteocytes and adipocytes when treated with 
magnetic nanotubes (Fig. 4). 
Additionally in the in vitro studies we investigated the possibility that CNTs and/or magnetic field 
may induce modification in the cytoskeleton of cells including the orientation of the actin filaments. 
We stained the actin filaments in cell incubated with nanotubes and exposed to a magnetic field and 
did not observe any different conformation and/or orientation of the actin in comparison to the 
control cells (Fig.5).  
In- vivo study 
This was designed to test the ability of magnetic MSCs to be shepherded in vivo towards a target 
organ – the liver. The cells were with magnetic CNTs for five days.  Thereafter, we injected one 
million cells in the hepatic portal vein of rats. Immediately after their injection, a magnet was 
placed on the abdominal wall overlying the liver and kept place overnight by a belt around the 
abdomen of the animal. In this experiment, the control animals received the same intra-portal dose 
of magnetic MSCs but had no magnet overlying the liver. The animals were sacrificed three weeks 
later with harvest of the organs for histological analysis. The distribution of the cells injected in the 
animals was ascertained by Prussian blue histochemical staining for intracellular detection of iron. 
In line with the reported literature, we performed these histochemical studies on serial sections of 
the liver, lungs and kidney. All the experiments were performed in triplicate. These histochemical 
studies revealed that magnetic stem cells were retained in the liver by the magnet with no evidence 
of either inflammation or neoplastic proliferation. We found significant differences by ANOVA 
analysis in the mean number of stained cells detected in the organs studied. As expected, the mean 
number of stained cells varied with the number of histological sections prepared for each organ 
(p<0.0001). The seminal finding related to the number of stained cells in the harvested livers:  those 
derived from animals treated with  a magnet overlying this organ had higher number of stained cells 
per histological section than in animals with livers not exposed to the magnetic field (6.284±1.349 
vs. 2.176±0.375; p=0.0053). In contrast, the kidneys and lungs derived from animals whose liver 
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had not been exposed to a magnetic field had higher mean values of stained cells: kidneys: 
10.800±3.038 vs. 6.464±1.915 (p=0.0050); lungs: 70.390±18.590 vs. 54.610±22.930 (p=0.0332). 
Significant differences in the number of stained cells/ tissue slice were found between liver and 
lung (p=0.0001), liver and kidney (p=0.0025) and kidney and lung (p=0.01309) (Fig.6 A and B). 
 
Discussion 
The experimental data obtained in this study confirm that magnetic fields can be used to control 
movement and location of MSCs cultured with carbon nanotubes. The cell density for control 
cultures MSCs in the Petri dish was homogeneous (350-400 cells/mm2), whereas the cell density 
was different in the test culture. Specifically, in the test culture the MSCs density ranged from 200 
cells/ mm2 to 800 cells/mm2, correlating respectively with  distances from the magnetic pole of 9-14 
mm and 5 mm. This cell streaming behaviour was closely related to the intensity of the flux density 
within the Petri dish which ranged from a very low value (<0.1 T) when the distance from the 
magnetic pole was >9 mm to about 0.5 T at a distance of 5 mm. Mathematically, an MSC 
interacting with CNTs is subjected to a translational force mF  in the presence of a gradient field of: 
dr
dBBVF rpm ⋅⋅⋅⋅= χµ0
1
          (1) 
where 0µ the magnetic permeability of is free space, rpχ  and V  are respectively the magnetic 
susceptibility and the total volume of magnetic nanotubes attached to the cell. Eq. 1 provides thus a 
mathematical tool to design the manipulation of MSCs cultured with carbon nanotubes by a 
magnetic flux gradient.  The migration dynamics of a single cell shows that the cell moves towards 
the magnetic source with a speed of approximating to 30 µm/h (see the dashed line crossing the cell 
nucleus of figure 2, supplementary materials). 
Cell proliferation assays were performed to exclude any adverse effect of the nanotubes and/or the 
magnetic field on the viability, proliferation and functionality of MSCs. Based on the experimental 
data reported by Wörle-Knirsch et al [34] we also used the WST-1 cell proliferation kit. The results 
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showed that the PF127 surfactant marginally decreased the cell viability but the in cell viability was 
negligible with PF127-CNTs. The latter may be explained by the action of the surfactant which 
wraps the nanotubes surface and reduces the amount of free PF127 in the medium [35]. 
Additionally, the data on the cell growth assays showed that the MSCs doubling time was not 
significantly influenced by the presence of both the nanotubes and the magnetic field and no 
apoptotic cells were observed in all samples studied.  
The in-vitro studies also confirmed that cells treated with CNTs up to 5 days maintain their ability 
to differentiate under specific conditions as well as the untreated cells. The lack of adverse effects 
on cell viability and proliferation by MWCNTs observed in the present study needs to be compared 
with the reported findings by Mooney et al. [36]. In this study, hMSCs were treated for 24 h with 
both COOH functionalised SWCNTs and OH-functionalised MWCNTs, at various concentrations. 
The authors demonstrated that COOH-functionalised SWCNT, used at concentration up to 32 
µg/ml, did not affect cells viability, proliferation, differentiation ability and metabolic activity; but 
at higher concentrations, SWCNTs exerted detrimental effects on the cells. In contrast, OH-
functionalised MWCNTs were found toxic at all concentrations. In the present study, the MWCNTs 
were not functionalised but simply dispersed in an anionic surfactant and used at concentration of 
10 µg/ml. Finally, the staining of the actin filaments suggested clearly that the treatment with the 
nanotubes and the exposure to the magnetic field did not alter cell morphology. 
The results of the in-vivo experiments demonstrate that MSCs cultured with CNTs can be 
shepherded by means of an external magnetic source towards a specific organ. This observation 
assumes importance in view of the widespread interest in recent years on MSC-based cell therapy 
for tissue engineering, regeneration/ repair of damaged organs and allogeneic transplantation. As 
MSCs also exhibit immuno-modulatory and anti-inflammatory effects they may play a role in the in 
vivo induction of tolerance.  Also they reduce the incidence and severity of GVHD [17-18], as well 
as prolonging skin graft survival [16].  
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The clinical applications of MSCs require the administration of cells by the intravenous route [26]; 
but their subsequent dispersion in many tissue and organs, [19-20-21] reduces the number of cells 
which colonize the intended target organ. There is therefore a need to increase targeted stem cell 
localization and homing to the diseased site. The approach proposed in this paper has the potential 
to achieve this objective of site-specific localization of the CNT treated MSCs, by reducing their 
colonisation of other sites with consequent adverse effects resulting from their proliferation and 
differentiation in ectopic sites. In the animal model studied we were able to achieve  a 3-fold 
increment of MSC localization in the target organ (liver) by this approach with a corresponding 
decrease of MSC localization in the lung.. In a recent work, Gao demonstrated that intravenous 
infusion of sodium nitroprusside, a vasodilator, administered prior to the cells infusion, reduced by 
15% the number of cells present in the lungs increasing by 10% the cells in the liver [19]. Based on 
this result we intend to investigate the combined action of a vasodilator and the magnetic guidance 
to enhance the targeted homing of cells. Additionally, we need to optimise the protocol and design 
and realize a magnetic applicator device which would allow a more precise and controlled 
configuration of the magnetic field gradient applied to the target site.  
 
Conclusion 
In the present study we have demonstrated that when mesenchymal stem cells (MSCs) are cultured 
in a CNT- containing medium, the nanotubes interact with the cells without compromising their 
viability and proliferation rate. Moreover we confirmed that magnetically labelled cells maintained 
the ability to differentiate in adipocytes and osteocytes.  As result of the cell interaction with CNTs, 
the application of a magnetic field, enables shepherding of MSCs to the desired location. In the 
experimental model used we were able to retain significantly more the mesenchymal stem cells 
within in the liver with a consequent reduction of their migration to other organs. 
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Executive Summary 
MWCNTs dispersion 
• Multi-wall carbon nanotubes (MWCNTs) have been efficiently dispersed in Pluronic F127.  
Cytocompatibility study on mesenchymal stem cells 
• MSCs showed excellent metabolic activity following 5-days incubation with cell culture medium 
modified with 10 µg/ml of MWCNTs.  
• Magnetic carbon nanotubes interact with MSCs without compromising their proliferation rate.  
• No apoptotic phenomenon was detected following incubation of MSCs with MWCNTs at 
concentrations of 10 µg/ml. 
• MSCs treated with magnetic nanotubes maintain their ability to differentiate in vitro into 
osteocytes and adipocytes. 
MSC magnetization with carbon nanotubes 
• Atomic force microscopy (AFM) analysis confirmed that MSCs cultured in a CNT-containing 
medium showed a strong interaction with the MWCNTs resulting in cell “magnetisation”.  
• The treatment with carbon nanotubes and magnetic fields does not alter cell phenotype.  
• MSCs treated with magnetic nanotubes move towards the magnetic source in vitro. 
• In vitro studies about the possible cytoskeleton modification induced by CNTs and/or magnetic 
field revealed that in cells incubated with nanotubes and exposed to a magnetic field there is no 
different conformation and/or orientation of the actin in comparison to the control cells. 
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In vivo studies  
• One million of  magnetized cells were injected in the hepatic portal vein of rats.  
• The application of a proper magnetic field changes the MSC biodistribution 
• The histochemical studies revealed an increment of CNT labelled MSC accumulation in the liver 
of the animals exposed to the magnetic field, with no evidence of either inflammation or neoplastic 
proliferation. 
Conclusions and perspectives 
• MWCNTs hold the potentiality to be used as nano-devices to improve the protocol for 
transplantation and homing of stem cells in vivo in numerous clinical applications.  
 
 
Legend to figures 
Fig.1 Imaging of MSCs shepherding: (A). MSC-CNT-cultures (a) MSC-control (b). Cultures 72 h 
after magnet placement. Images taken at different distances from the magnet pole (1, 2 and 3 
correspond respectively to 5, 9 mm and 14 mm from the magnetic pole). Cell is stained with Syto 
82 fluorescent dye. (B). MSC density for test and control cultures after 72 h from the magnet 
placement at different distances from the magnet pole. Assays performed in quadruple and results 
are the mean±S.E.M. (vertical bars). 
Fig.2 Cell proliferation assay: Cell viability assay for MSCs cultured with the control medium 
(K), the PF127-CNT-modified medium and PF127 modified medium. The viability was measured 
with the WST-1 assay and results are given in percent related to untreated controls. Results are the 
mean±S.E.M. (vertical bars) of four experiments each carried out in six-plicate. 
Fig.3 MSCs doubling time: Cells were cultured in culture medium and in PF127-CNT-modified 
medium, with and without the external magnetic field B; Data expressed as mean ± S.E.M. of three 
experiments each carried out in quadruple. 
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Fig.4 Osteogenic and Adipogenic stem cell differentiation. Osteogenic differentiation: (A) 
Control stem cells; (B) Stem cell treated with magnetic nanotubes; (C) Stem cell treated with 
PF127. Adipogenic differentiation: (D) Control stem cells; (E) Stem cell treated with magnetic 
nanotubes; (F) Stem cell treated with PF127. 
Fig.5 Staining of cell cytoskeletal actin: (A) Control MSCs; (B) MSCs incubated with nanotubes 
in presence of magnetic field.  
Fig.6  Histochemical analysis: (A) Liver’s section with Perls labelled mesenchymal stem cells 
with magnetic nanotubes; (B) Mean and S.E.M. values of positive cells for Perls staining in each 
type of organ.  
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